Skip to content
Free shipping on orders of $100+. Some exclusions apply.
Subscribe & Save 15% off Subcription Orders.
  • About Us
    About Us
    • Our Story
    • How We Work
    • People
    • Business Development
  • Science
    Science
    • Scientific Approach
    • Published Scientific Papers
  • Pipeline
  • Products
    Products
    • Metabolic Switch
      Metabolic Switch
      • Shop
      • User Guide
      • Recipes
      • FAQs
    • Learn
      Learn
      • Ketosis & Metabolism
      • Healthy Aging & Lifestyle
      • Mind, Body & Fitness
      • Nutrition & Recipes
  • Investors
    Investors
    • Press Releases
    • In the News
    • Longevity - Coming of Age Conference
Log in
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • LinkedIn
Juvenescence LogoJuvenescence Logo
  • About Us
    • Our Story
    • How We Work
    • People
    • Business Development
  • Science
    • Scientific Approach
    • Published Scientific Papers
  • Pipeline
  • Products
    • Metabolic Switch
      • Shop
      • User Guide
      • Recipes
      • FAQs
    • Learn
      • Ketosis & Metabolism
      • Healthy Aging & Lifestyle
      • Mind, Body & Fitness
      • Nutrition & Recipes
  • Investors
    • Press Releases
    • In the News
    • Longevity - Coming of Age Conference
Log in
Cart

Press Releases

  • All
  • AgeX
  • Chrysea Labs
  • Conference
  • Evgen Pharma
  • Juvenescence
  • LyGenesis
  • MDI Therapeutics
  • Morphoceuticals
  • Napa Therapeutics
  • NetraMark Corp.
  • Relation Therapeutics
  • Selah Therapeutics
  • Souvien Therapeutics
  • The Buck Institute

Juvenescence closes First $46M Tranche of $100M Series B

January 16, 2019

Juvenescence is pleased to announce the close of the first tranche of its Series B financing, in the amount of $46 million.

Read more

Juvenescence Series A, Nets $50 Million

June 11, 2018

Juvenescence has successfully raised $50 million in its Series A financing. The Series A financing was oversubscribed with participation from founders, insiders, institutional investors and family offices.

Read more

Juvenescence Closes Seed Round of USD $12.3 Million with Participation from Seasoned Biotech Investors

January 08, 2018

Juvenescence announced that it has closed its seed funding round, raising USD $12.3 million. The Seed Round was included undisclosed sums from a range of seasoned international angel investors and...

Read more
  • ‹ Prev
  • 1
  • 2

  • Contact Us
  • Privacy Notice
  • Terms of Service
  • Cookie Notice
  • Refund Policy
  • Offers & Promotions

Juvenescence Aging & Longevity News

Sign up for the latest thought leadership, insights and news about Juvenescence and the Aging & Longevity space.

Stay connected.

  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • LinkedIn
  • Follow us on social media!
© 2023, Juvenescence. Consult with your physician prior to use and for any advice regarding specific medical conditions. Information on this website is provided as general information only and not an endorsement or promotion of any particular therapy or product, including any product offered for sale on this website. These statements have not been evaluated by the Food and Drug Administration. Not intended to diagnose, treat, prevent or cure any disease.
  • Choosing a selection results in a full page refresh.